Advancing treatments for rare diseases together

Impact of our model

Our not-for-profit model multiplies the impact of philanthropic investments and pharmaceutical know-how to alleviate the suffering of millions of children with rare diseases and their families

We are committed to use funding resources in a socially responsible manner. We reinvest all our profits to further achieve our mission, which is to develop treatments for underserved patients, improve their quality of life and drive affordable access to medicine. 

EspeRare uses philanthropic investment to create new therapy, to treat tens of patient. Profits are reinvested to create new therapies to treat more rare diseases. It is EspeRare's exponential impact.

Investments and financial returns enable EspeRare to establish itself as a major drug development player within the paediatric rare disease space and confirm its ability to accelerate accessible treatments for these underserved patients.